IVI - International Vaccine Institute

ivi-main-program-01

ivi-img-05-1-25

ivi-img-main-04-img-02

ivi-main-program-04

IVI News & Announcements

IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

IVI to strengthen COVID-19 surveillance in sub-Saharan Africa with support from Sweden

The IVI Blog

‘Present and Future of Vaccine Development’ Seminar series: Genetic Engineering of Vibrio cholerae strains to fight against cholera

Giving Ambassador, Violinist Lee Sang Hee holds ’16th Recital with IVI’

Present and Future of Vaccine Development’ seminar series: Improved vaccine for foot-and-mouth-disease control

Global Partners

ivi-main-mobile-04

ivi-main-mobile-03

ivi-main-mobile-01

ivi-main-mobile-02

IVI News &
Announcements

IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

IVI to strengthen COVID-19 surveillance in sub-Saharan Africa with support from Sweden

The IVI Blog

‘Present and Future of Vaccine Development’ Seminar series: Genetic Engineering of Vibrio cholerae strains to fight against cholera

Giving Ambassador, Violinist Lee Sang Hee holds ’16th Recital with IVI’

Present and Future of Vaccine Development’ seminar series: Improved vaccine for foot-and-mouth-disease control

Global Partners